DOI: 10.1055/s-00023610

Drug Research

Ausgabe 01 · Volume 68 · Januar 2018 DOI: 10.1055/s-007-36214

Erratum

e1
Hasanifard, Leili; Samadi, Nasser; Rashtchizadeh, Nadereh; Dastmalchi, Siavoush; Karimi, Pouran: Correction: Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression

Review

5
Minuth, Will W.: Action Plan for Prolongation of Nephrogenesis in Preterm and Growth Restricted Babies: Explore Ultrastructure of the Nephrogenic Zone, Identify a Molecular Target, Select a Viable Drug and Find a Path for Administration

Original Article

17
Ranjbar-Karimi, Reza; Poorfreidoni, Alireza: Incorporation of Fluorinated Pyridine in the Side Chain of 4-Aminoquinolines: Synthesis, Characterization and Antibacterial Activity
Supporting Information
23
Adeoye, Bisi Olajumoke; Asenuga, Ebunoluwa Racheal; Oyagbemi, Ademola Adetokunbo; Omobowale, Temidayo Olutayo; Adedapo, Adeolu A: The Protective Effect of the Ethanol Leaf Extract of Andrographis Paniculata on Cisplatin-Induced Acute Kidney Injury in Rats Through nrf2/KIM-1 Signalling Pathway
33
Ghavimi, Hamed; Darvishi, Sara; Ghanbarzadeh, Saeed: Attenuation of Morphine-Induced Tolerance and Dependence by Pretreatment with Cerebrolysin in Male rats
38
Ishiura, Yoshihisa; Fujimura, Masaki; Shiba, Yasutaka; Ohkura, Noriyuki; Hara, Johsuke; Abo, Miki; Kasahara, Kazuo: A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics
45
Hasanifard, Leili; Samadi, Nasser; Rashtchizadeh, Nadereh; Dastmalchi, Siavoush; Karimi, Pouran: Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression
54
Idkaidek, Nasir; Agha, Haneen; Arafat, Tawfiq: Saliva versus Plasma Bioequivalence of Valsartan/Hydrochlorothiazide in Humans: Validation of Classes II and IV Drugs of the Salivary Excretion Classification System

Letter

60
Derakhshan, Iraj: Daily Scheduled Opioids as Monotherapy for Prevention of Migraine-Triggered Epilepsy